MedAdvisor Dirección

Dirección controles de criterios 0/4

Actualmente no disponemos de información suficiente sobre el CEO.

Información clave

Rick Ratliff

Chief Executive Officer (CEO)

AU$2.0m

Compensación total

Porcentaje del salario del CEO	33.4%
Permanencia del CEO	1.8yrs
Participación del CEO	n/a
Permanencia media de la dirección	1.5yrs
Promedio de permanencia en la Junta Directiva	2.4yrs

Actualizaciones recientes de la dirección

Recent updates

Increases to MedAdvisor Limited's (ASX:MDR) CEO Compensation Might Cool off for now

Nov 09

Is MedAdvisor (ASX:MDR) A Risky Investment?

Oct 11

Is MedAdvisor (ASX:MDR) Using Too Much Debt?

Mar 08

MedAdvisor (ASX:MDR) Shareholders Have Enjoyed A 41% Share Price Gain

Feb 10

What Can We Make Of MedAdvisor's (ASX:MDR) CEO Compensation?

Jan 18

The Non-Executive Chairman of the Board of MedAdvisor Limited (ASX:MDR), Christopher Ridd, Just Bought A Few More Shares

Dec 22

What Kind Of Investors Own Most Of MedAdvisor Limited (ASX:MDR)?

Dec 18

Here's Why We're Not Too Worried About MedAdvisor's (ASX:MDR) Cash Burn Situation

Nov 22

Análisis de compensación del CEO

¿Cómo ha cambiado la remuneración de Rick Ratliff en comparación con los beneficios de MedAdvisor?
Fecha	Compensación total	Salario	Ingresos de la empresa
Dec 31 2023	n/a	n/a	-AU$9m
Sep 30 2023	n/a	n/a	-AU$10m
Jun 30 2023	AU$2m	AU$678k	-AU$11m

Compensación vs. Mercado: Rick($USD1.33M) está por encima de la media de empresas de tamaño similar en el mercado Australian ($USD292.11K).

Compensación vs. Ingresos: Datos insuficientes para comparar la remuneración de Rick con los resultados de la empresa.

CEO

Rick Ratliff

1.8yrs

Permanencia

AU$2,030,589

Compensación

Mr. Richard Ratliff, also known as Rick, MBA IT, BChE serves as Chief Executive Officer & Managing Director and Director at MedAdvisor Limited since July 15, 2022. He serves as Chief Commercial Officer at...

Equipo directivo

Nombre	Posición	Permanencia	Compensación	Propiedad
Richard Ratliff	CEO, MD & Director	1.8yrs	AU$2.03m	sin datos
Ancila Desai	CFO & Joint Company Secretary	1.5yrs	AU$461.20k	sin datos
Craig Schnuriger	Acting Chief Technology Officer	4.1yrs	sin datos	sin datos
James Rotsart	Executive VP of US & Client Relations	no data	sin datos	sin datos
Wayne Marinoff	President of ANZ	1.3yrs	sin datos	sin datos
Anshu Raghuvanshi	Joint Company Secretary	1.1yrs	sin datos	sin datos

1.5yrs

Permanencia media

Equipo directivo experimentado: MDREl equipo directivo de la empresa no se considera experimentado ( 1.3 años de permanencia media), lo que sugiere un nuevo equipo.

Miembros de la Junta

Nombre	Posición	Permanencia	Compensación	Propiedad
Richard Ratliff	CEO, MD & Director	1.8yrs	AU$2.03m	sin datos
Linda Jenkinson	Independent Non-Executive Chairman	2.2yrs	AU$373.08k	sin datos
Kevin Hutchinson	Independent Non-Executive Director	1.4yrs	AU$102.62k	0.11% A$ 149.8k
Lucas Merrow	Independent Non-Executive Director	2.7yrs	AU$94.10k	0.17% A$ 239.8k
Sandra Hook	Independent Non-Executive Director	8.3yrs	AU$130.78k	0.056% A$ 78.9k
Arthur Charlaftis	Member of Advisory Board	8.1yrs	sin datos	sin datos
Jim Xenos	Non-Executive Director	8.4yrs	AU$84.58k	1.25% A$ 1.8m
Mike Da Gama	Member of Advisory Board	8.1yrs	AU$25.89k	sin datos
Nick England	Member of Advisory Board	8.1yrs	sin datos	sin datos
Catherine Hill	Independent Non-Executive Director	less than a year	AU$5.78k	sin datos
Anthony Tassone	Non-Executive Director	1.8yrs	sin datos	sin datos
Brett Magun	Non-Executive Director	less than a year	sin datos	sin datos

2.4yrs

Permanencia media

Junta con experiencia: La junta directiva de MDR no se considera experimentada (2.3 años de permanencia promedio), lo que sugiere una nueva junta directiva.

MedAdvisor Dirección

Dirección controles de criterios 0/4

Información clave

Actualizaciones recientes de la dirección

Non-Executive Director recently bought AU$1.2m worth of stock

MedAdvisor Limited, Annual General Meeting, Nov 28, 2023

MedAdvisor Limited Announces Board Changes

MedAdvisor Limited Appoints Kevin Hutchinson as Director

Less than half of directors are independent

MedAdvisor Limited Announces Board Changes

Recent updates

Are Investors Undervaluing MedAdvisor Limited (ASX:MDR) By 44%?

Forecast breakeven date pushed back to 2026

New minor risk - Profitability

Now 24% overvalued after recent price rise

Consensus estimates of losses per share improve by 33%

Health Check: How Prudently Does MedAdvisor (ASX:MDR) Use Debt?

Non-Executive Director recently bought AU$1.2m worth of stock

MedAdvisor Limited, Annual General Meeting, Nov 28, 2023

Consensus estimates of losses per share improve by 32%

Full year 2023 earnings: EPS misses analyst expectations

Consensus EPS estimates fall by 50%

MedAdvisor Limited Announces Board Changes

Health Check: How Prudently Does MedAdvisor (ASX:MDR) Use Debt?

Consensus EPS estimates fall by 80%, revenue upgraded

First half 2023 earnings released: EPS: AU$0.009 (vs AU$0.02 loss in 1H 2022)

Price target increased to AU$0.40

MedAdvisor Limited Provides Revenue Guidance for the First Half of the Fiscal Year 2023

MedAdvisor Limited Appoints Kevin Hutchinson as Director

Less than half of directors are independent

MedAdvisor Limited to Report Q1, 2023 Results on Oct 28, 2022

MedAdvisor Limited Announces Board Changes

MedAdvisor Limited, Annual General Meeting, Nov 30, 2022

Full year 2022 earnings: EPS and revenues miss analyst expectations

MedAdvisor Limited (ASX:MDR) entered a binding agreement to acquire GuildLink Pty Ltd from Guild Group Holdings Limited for AUD 8 million.

MedAdvisor Limited Announces Executive Changes

MedAdvisor (ASX:MDR) Is Carrying A Fair Bit Of Debt

MedAdvisor Limited Announces Change of Managing Director

Price target decreased to AU$0.40

No longer forecast to breakeven

Less than half of directors are independent

MedAdvisor Limited Announces Retirement of Robert Read as CEO

Consensus forecasts updated

MedAdvisor Limited Announces Board Changes

MedAdvisor Limited to Report First Half, 2022 Results on Feb 25, 2022

MedAdvisor Limited Appoints Raeann Grossman to the Board as A Non-Executive Director

Independent Non-Executive Director Peter Bennetto has left the company

Non-Executive Director recently sold AU$2.5m worth of stock

Increases to MedAdvisor Limited's (ASX:MDR) CEO Compensation Might Cool off for now

Is MedAdvisor (ASX:MDR) A Risky Investment?

Less than half of directors are independent

Full year 2021 earnings released

Non-Executive Director has left the company

MedAdvisor Limited announced that it has received AUD 5.25 million in funding

New 90-day low: AU$0.34

Is MedAdvisor (ASX:MDR) Using Too Much Debt?

First half 2021 earnings released: AU$0.029 loss per share (vs AU$0.024 loss in 1H 2020)

MedAdvisor Limited to Report First Half, 2021 Results on Feb 25, 2021

MedAdvisor (ASX:MDR) Shareholders Have Enjoyed A 41% Share Price Gain

What Can We Make Of MedAdvisor's (ASX:MDR) CEO Compensation?

New 90-day low: AU$0.34

Non-Executive Chairman of the Board recently bought AU$70k worth of stock

The Non-Executive Chairman of the Board of MedAdvisor Limited (ASX:MDR), Christopher Ridd, Just Bought A Few More Shares

MedAdvisor Limited Signs an Additional One-Year Deal with A Major Global Pharmaceutical Company

What Kind Of Investors Own Most Of MedAdvisor Limited (ASX:MDR)?

New 90-day low: AU$0.36

Here's Why We're Not Too Worried About MedAdvisor's (ASX:MDR) Cash Burn Situation

New 90-day low: AU$0.39

MedAdvisor Limited Extends Health Programs in the US

New 90-day low: AU$0.41

MedAdvisor Limited Launches ePrescribing across Australia

New 90-day low - AU$0.44

Full year earnings released

New 90-day low - AU$0.45

Análisis de compensación del CEO

CEO

Permanencia

Compensación

Equipo directivo

Permanencia media